Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
L.FaheyR
983-992, Kayesh M, et al
Consequently, the development of therapeutic agents that disrupt various aspects of Gln metabolism may represent a promising anticancer strategy ( Figure 2 )
BPC-157 may be particularly suited to this route of administration due to its known neuroprotective benefits
doi:10.1177/0748233709348393 Islam, M.T., Mishra, S.K., Tripathi, S., de Alencar, M.V.O.B., e Sousa, J.M.d.C., Rolim, H.M.L., de Medeiros, M.d.G.F., Ferreira, P.M.P., Rouf, R., Uddin, S.J., Mubarak, M.S
US$ 29.87
US$ 25.41
US$ 29.57
US$ 27.37
US$ 20.93
US$ 26.31
US$ 25.97
